这种倾向被制药公司发送给医师们的营销信息强化了。 这些信息强调对双相障碍诊断延误和认识不足的研究，就有可能使医师们变得敏感。
This bias is reinforced by the marketing message of pharmaceutical companies to physicians, which has emphasized research on delayed diagnosis and under-recognition of bipolar disorder, possibly sensitizing clinicians accordingly.